Prelude Capital Management, LLC 10x Genomics, Inc. Transaction History

Prelude Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$36.08 - $54.3 $207,568 - $312,387	5,753 New	5,753 $215,000
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $187,179 - $253,069	-1,386 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$145.58 - $192.14 $236,130 - $311,651	-1,622 Reduced 53.92%	1,386 $202,000
Q2 2021 Aug 16, 2021	BUY	$134.22 - $202.37 $86,169 - $129,921	642 Added 27.13%	3,008 $589,000
Q1 2021 May 17, 2021	SELL	$140.25 - $196.86 $44,459 - $62,404	-317 Reduced 11.82%	2,366 $428,000
Q4 2020 Feb 16, 2021	BUY	$126.47 - $163.7 $62,476 - $80,867	494 Added 22.57%	2,683 $380,000
Q3 2020 Nov 16, 2020	BUY	$87.44 - $125.0 $108,338 - $154,875	1,239 Added 130.42%	2,189 $273,000
Q2 2020 Aug 14, 2020	BUY	$58.39 - $89.31 $55,470 - $84,844	950 New	950 $85,000

284

96.2M

162K

107K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $2.15B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.